Contec Medical Systems Co (300869.SZ) Stock Price

Contec Medical Systems Co Ltd generates revenue through the research, manufacture, and distribution of medical instruments including oximeters, electrocardiographs, ultrasound equipment, patient monitors, sphygmomanometers, and related products. The company sells desktop oximeters, multi-parameter patient monitors, ECG devices, ultrasound Doppler fetal heart rate monitors, ambulatory blood pressure monitors, and dynamic electroencephalogram systems to hospitals at all levels, outpatient departments, community health centers, village clinics, physical examination centers, elderly care facilities, families, individuals, enterprises, and institutions. Its domestic market and international markets include the United States, European Union, Japan, and South Africa, where it distributes its medical devices for use in clinical and personal health monitoring applications. The company's product portfolio targets healthcare providers and end-users across various segments, with a focus on diagnostic and monitoring equipment for both professional and personal use. Hospitals, clinics, and health centers purchase these devices for clinical applications, while individuals and families buy them for home health monitoring. Enterprises and institutions also acquire the products for workplace health screenings. The international markets of the United States, European Union, Japan, and South Africa represent key export destinations where Contec Medical Systems Co Ltd distributes its medical instruments to meet regional healthcare needs. Contec Medical Systems Co Ltd's revenue streams are derived from the sale of its medical instruments to a diverse customer base spanning healthcare facilities, community health services, and personal end-users. The company's products are utilized in multiple settings including hospitals, outpatient departments, community health centers, village clinics, physical examination centers, elderly care institutions, and home environments, ensuring broad market penetration. By serving both domestic and international markets, the company capitalizes on demand for medical monitoring and diagnostic tools in both developed and emerging economies.